Status:
ACTIVE_NOT_RECRUITING
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
Lead Sponsor:
ZIWIG
Collaborating Sponsors:
Monitoring Force Group
iGenSeq
Conditions:
Ovarian Cancer
Ovarian Cyst Benign
Eligibility:
FEMALE
18+ years
Brief Summary
OVAmiARN is a multicentre, prospective, longitudinal, non-interventional, observational study carried out in 8 obstetrics and gynecology departments in France; in order to describe the evolution of sa...
Eligibility Criteria
Inclusion Criteria:
- Patient over 18 years of age,
- A patient with an ovarian adnexal mass diagnosed by clinical examination and imaging and likely to be ovarian cancer, a borderline tumour or a benign cyst,
- Patient with an indication for surgery
- Patient has dated and signed the consent form,
- Patient affiliated to the healthcare system,
Exclusion Criteria:
- Pregnant patient
- Patient infected with human immunodeficiency virus (HIV),
- Patient with significant difficulties in reading or writing the French language.
- Patient with another diagnosed cancer
- Patient with a history of cancer less than 5 years old
Key Trial Info
Start Date :
May 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2027
Estimated Enrollment :
746 Patients enrolled
Trial Details
Trial ID
NCT05514028
Start Date
May 4 2022
End Date
April 1 2027
Last Update
March 30 2026
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Caen
Caen, Calvados, France, 14000
2
CGFL
Dijon, Côte d'Or, France, 21079
3
Institut Bergonié
Bordeaux, Gironde, France, 33076
4
CHU Strasbourg
Strasbourg, Haut-Rhin, France, 67200